PubRank

J Reimann

Author PubWeight™ 126.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997 2.28
2 MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996 2.12
3 Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand 2009 1.57
4 Sequence and organization of the diversity, joining, and constant region genes of the human T-cell delta-chain locus. Proc Natl Acad Sci U S A 1988 1.53
5 T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. J Immunol 1998 1.44
6 Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 2001 1.43
7 Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 2008 1.41
8 Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol 1999 1.34
9 A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods 1985 1.33
10 Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol 1995 1.31
11 Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997 1.29
12 Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995 1.25
13 Diversity and structure of human T cell receptor delta chain genes in peripheral blood gamma/delta-bearing T lymphocytes. J Exp Med 1989 1.22
14 Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol 1994 1.21
15 Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J Immunol 1994 1.20
16 Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol 2001 1.17
17 Sequence and organization of the human T cell delta chain gene. Eur J Immunol 1988 1.13
18 DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 1995 1.12
19 The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am J Pathol 2000 1.12
20 DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J Immunol 1996 1.12
21 Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J Virol 1999 1.11
22 IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J Immunol 2001 1.11
23 CD3+ T cells in severe combined immune deficiency (scid) mice. I. Transferred purified CD4+ T cells, but not CD8+ T cells are engrafted in the spleen of congenic scid mice. Eur J Immunol 1991 1.08
24 Polyclonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis. Eur J Immunol 1996 1.07
25 Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J Immunol 2001 1.06
26 CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996 1.05
27 DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int Immunol 1997 1.03
28 Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest 2001 1.03
29 Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol 2001 1.02
30 Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol 1994 1.02
31 Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Virology 1997 1.00
32 Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. Nucleic Acids Res 2010 1.00
33 Characterization of cells with T cell markers in athymic nude bone marrow and of their in vitro-derived clonal progeny. Comparison with euthymic bone marrow. J Immunol 1990 0.98
34 Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J Neurol Sci 2003 0.97
35 Double-negative (CD4-CD8-), TCR alpha beta-expressing, peripheral T cells. Scand J Immunol 1991 0.96
36 Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol 1995 0.96
37 Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology 1996 0.95
38 Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event? Immunology 1981 0.94
39 Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 1997 0.94
40 Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen. Eur J Immunol 1998 0.94
41 DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann N Y Acad Sci 1995 0.93
42 Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 1994 0.93
43 PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae. Vaccine 2001 0.93
44 CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol 1994 0.93
45 Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur J Immunol 1994 0.93
46 Change of carbon source causes dramatic effects in the phospho-proteome of the archaeon Sulfolobus solfataricus. J Proteome Res 2012 0.92
47 MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts. J Immunol 2001 0.92
48 CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Eur J Immunol 1991 0.92
49 In vitro proliferation of haemopoietic cells in the presence of adherent cell layers. II. Differential effect of adherent cell layers derived from various organs. Exp Hematol 1979 0.92
50 Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol 1995 0.91
51 Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 2008 0.90
52 Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide. J Mol Med (Berl) 2001 0.89
53 Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitis. Eur J Immunol 1996 0.89
54 Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins. Clin Chem Lab Med 1999 0.89
55 Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques. Intervirology 1996 0.88
56 In vitro proliferation of haemopoietic cells in the presence of adherent cell layers. I. Culture conditions and strain dependence. Exp Hematol 1979 0.88
57 Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. J Proteomics 2013 0.87
58 Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 1998 0.87
59 Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 1998 0.87
60 Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen. Biol Chem 2001 0.86
61 Association of plectin with Z-discs is a prerequisite for the formation of the intermyofibrillar desmin cytoskeleton. Lab Invest 2000 0.86
62 Natural occurrence of Fusarium toxins in oats harvested during five years in an area of southwest Germany. Food Addit Contam 1998 0.86
63 Polyvalent DNA vaccines with bidirectional promoters. J Mol Med (Berl) 2000 0.86
64 Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. Virology 1996 0.86
65 DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur J Immunol 1999 0.86
66 'Empty' Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation. Eur J Immunol 1996 0.86
67 Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Intervirology 2001 0.86
68 Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur J Immunol 1994 0.85
69 Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes. Eur J Immunol 1993 0.85
70 DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J Immunol Methods 1996 0.85
71 Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes. Clin Exp Immunol 1981 0.85
72 Tumour necrosis factor-alpha (TNF-alpha) transcription and translation in the CD4+ T cell-transplanted scid mouse model of colitis. Clin Exp Immunol 1999 0.84
73 A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice. Infect Immun 1996 0.84
74 Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentation. Eur J Immunol 1997 0.84
75 Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 1998 0.84
76 Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol 2001 0.83
77 Antigen-presenting T cells. II. Clonal responses of alloreactive and virus-specific self-restricted human cytotoxic T cell responses stimulated by T lymphoblasts. J Immunol 1987 0.83
78 Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice. Eur J Immunol 1992 0.83
79 Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord 2003 0.83
80 "Self-reactive" T cells. I. In vivo reaction of T cells to transferred polyclonally activated syngeneic and autologous lymphoblasts. Immunobiology 1980 0.83
81 The pregnancy-related dreams of pregnant women. J Am Board Fam Pract 1993 0.83
82 Regional specialization of intraepithelial T cells in the murine small and large intestine. Scand J Immunol 1995 0.83
83 Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers. J Exp Med 1983 0.83
84 Introduction of a selectable gene into murine T-lymphoblasts by a retroviral vector. J Immunol Methods 1986 0.83
85 DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J Immunol 1996 0.82
86 The veto phenomenon in T-cell regulation. Ann N Y Acad Sci 1988 0.82
87 Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control. Vaccine 2000 0.82
88 Monocyte inflammatory protein-1 alpha facilitates priming of CD8(+) T cell responses to exogenous viral antigen. Int Immunol 2000 0.82
89 CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells. Eur J Immunol 1991 0.82
90 Fusarium toxins in wheat harvested during six years in an area of southwest Germany. Nat Toxins 1997 0.82
91 Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol 1999 0.82
92 [Cogan I syndrome: too often detected too late? A contribution to early diagnosis of Cogan I syndrome]. Klin Monbl Augenheilkd 1995 0.82
93 Immunoglobulin leakiness in scid mice with CD4(+) T-cell-induced chronic colitis. Clin Immunol 2000 0.82
94 Lamina propria T cell subsets in the small and large intestine of euthymic and athymic mice. Scand J Immunol 1995 0.81
95 Proliferation and apoptosis of lamina propria CD4+ T cells from scid mice with inflammatory bowel disease. Eur J Immunol 1998 0.81
96 Proton transfer in bacterial nitric oxide reductase. Biochem Soc Trans 2006 0.81
97 Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells. J Virol Methods 1999 0.81
98 Early and selective disappearance of telethonin protein from the sarcomere in neurogenic atrophy. J Muscle Res Cell Motil 2001 0.81
99 Transplantation of CD4+ T cell clones into SCID mice. J Immunol Methods 1993 0.81
100 Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 1995 0.81
101 Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen. J Immunol 2000 0.81
102 Preferential development of gamma/delta-bearing T cells in athymic nude bone marrow. Curr Top Microbiol Immunol 1991 0.80
103 "Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells. Immunobiology 1980 0.80
104 Polymorphism and MHC gene function. Dev Comp Immunol 1983 0.80
105 [Clinical and genetic findings in a patient with fundus albipunctatus]. Ophthalmologe 2004 0.80
106 Use of V beta.8 genes in splenic Lyt-2+ cytotoxic lymphocyte precursors reactive to bm1 or bm14 alloantigen in individual C57BL/6 mice. Eur J Immunol 1986 0.80
107 Generation of autoreactive cytotoxic T lymphocytes under limiting dilution conditions. J Immunol 1983 0.80
108 Expression of selectin-binding epitopes and cytokines by CD4+ T cells repopulating scid mice with colitis. Eur J Immunol 1998 0.80
109 Differential binding of lectins to lymphopoietic and myelopoietic cells in murine marrow as revealed by flow cytometry. Cytometry 1984 0.80
110 Clonal activation of cytotoxic lymphocyte precursors by monoclonal anti-CD3 antibody: analysis of feeder cell requirements. Immunol Lett 1987 0.79
111 Natural occurrence of Fusarium toxins in barley harvested during five years in an area of southwest Germany. Mycopathologia 1997 0.79
112 Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen. Int Immunol 1999 0.79
113 Oestrogen treatment depletes extrathymic T cells from intestinal lymphoid tissues. Scand J Immunol 1996 0.79
114 Hohenheimer Consensus Talk. Oxidative and premature skin ageing. Exp Dermatol 2003 0.79
115 Rapid changes in specificity within single clones of cytolytic effector cells. Cell 1985 0.78
116 Adoptive transfer of low numbers of CD4+ T cells into SCID mice chronically treated with soluble IL-4 receptor does not prevent engraftment of IL-4-producing T cells. Scand J Immunol 1993 0.78
117 Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin. Eur J Immunol 1997 0.78
118 CD3+ T cells in severe combined immunodeficiency (scid) mice. VI. Rescue of scid-derived, IgM-producing B cells by transfer of CD4+ CD8- T cells from various lymphoid organs. Immunology 1992 0.78
119 DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD mice. Horm Metab Res 1998 0.78
120 [Micronutrients and their relevance for the eye--function of lutein, zeaxanthin and omega-3 fatty acids]. Klin Monbl Augenheilkd 2010 0.78
121 Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro. J Mol Cell Immunol 1987 0.78
122 Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL. Eur J Immunol 1994 0.78
123 Host-reactive cytotoxic T lymphocyte precursors in long-lived fully allogeneic mouse bone marrow chimeras. Scand J Immunol 1986 0.78
124 In situ characterization of genetically targeted (green fluorescent) single cells and their microenvironment in an adoptive host. Am J Pathol 2001 0.77
125 Survival and revival times of the retina: ERG studies at total ocular ischemia in rabbits and cats. Doc Ophthalmol 1986 0.77
126 Cellular and molecular composition of human skin in long-term xenografts on SCID mice. Exp Dermatol 1993 0.77
127 DNA-Based Vaccination with Polycistronic Expression Plasmids. Methods Mol Med 2000 0.77
128 Transforming growth factor-beta messenger RNA and protein in murine colitis. J Histochem Cytochem 2001 0.77
129 Stable engraftment of human female genital mucous membrane xenografts on SCID mice. Gynecol Obstet Invest 1995 0.77
130 Alloreactive cytotoxic T cells. I. Alloreactive and allorestricted cytotoxic T cells. Eur J Immunol 1985 0.76
131 Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development. Behring Inst Mitt 1994 0.76
132 Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in severe combined immunodeficient (scid) mice with T cell-induced inflammatory bowel disease (IBD). Clin Exp Immunol 1998 0.76
133 Diversity of functional T-cell receptor delta-chain transcripts from bone marrow cells of athymic nude mice. Immunology 1993 0.76
134 [Multifocal motor neuropathy: diagnosis and differential diagnosis]. Nervenarzt 2002 0.75
135 Allorestricted cytotoxic T cells. Large numbers of allo-H-2Kb-restricted antihapten and antiviral cytotoxic T cell populations clonally develop in vitro from murine splenic precursor T cells. J Exp Med 1985 0.75
136 A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen. Immunology 1994 0.75
137 DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kDa heat shock protein. Med Microbiol Immunol 2000 0.75
138 Lymphoblastogenesis stimulates proliferation of interacting Lyt1 T cells in a syngeneic system. Eur J Immunol 1981 0.75
139 MMPI-2 profiles of Colombian, Mexican, and Venezuelan university students. Psychol Rep 2000 0.75
140 H-2 class I Ld antigen positively selects different TCR V beta gene products in CD8+ and CD4+ T cells. Scand J Immunol 1992 0.75
141 [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy]. Rofo 1984 0.75
142 Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejection. Cancer Immunol Immunother 1997 0.75
143 Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells. Biol Chem 1999 0.75
144 Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma. Z Gastroenterol 1999 0.75
145 Further survey of the occurrence of Fusarium toxins in wheat grown in southwest Germany. Arch Tierernahr 2001 0.75
146 The diversity of in-frame TCR delta chain transcripts in aging SCID mice. Int Immunol 1993 0.75
147 Bone marrow cells of athymic nude mice express functional T cell receptor alpha chain transcripts rearranged to V delta 2, 3, 4, 5, 6 genes. Eur J Immunol 1992 0.75
148 [Familial renal-retinal dysplasia - a combination of eye and kidney malformations]. Z Arztl Fortbild (Jena) 1980 0.75
149 T-cell reactivity to polymorphic MHC determinants. II. Self-reactive and self-restricted T cells. Curr Top Microbiol Immunol 1986 0.75
150 Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression. Eur J Immunol 1999 0.75
151 A pancolitis resembling human ulcerative colitis (UC) is induced by CD4+ TCR alphabeta T cells of athymic origin in histocompatible severe combined immunodeficient (SCID) mice. Clin Exp Immunol 1998 0.75
152 Specificity repertoire of splenic Lyt-2+/F23+ cytotoxic lymphocyte precursors from B6 mice. Cell Immunol 1987 0.75
153 Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin. J Immunol 1987 0.75
154 [Pathogenetic models ulcerative colitis and Crohn disease]. Verh Dtsch Ges Pathol 1996 0.75
155 CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity. Scand J Immunol 1991 0.75
156 T-cell reactivity to polymorphic MHC determinants. III. Alloreactive and allorestricted T cells. Curr Top Microbiol Immunol 1986 0.75
157 [Macrophagic myofasciitis: inflammatory, vaccination-associated muscular disease]. Dtsch Med Wochenschr 2003 0.75
158 Fibre content and cellularity of the bone marrow of the iliac crest, vertebral column and sternum in chronic myeloproliferative disorders. Leuk Lymphoma 2000 0.75
159 Self-reactive T cells. V. T cell-mediated suppression of B cell responsiveness to LPS. Immunobiology 1981 0.75
160 Self-reactive T cells. IV. Self-reactive T cells induce polyclonal differentiation of IgM-producing B cells in vivo and in vitro. Immunobiology 1981 0.75
161 Proceedings: Survival and revival times of the retina and their dependence on retinal temperature. Experimental studies on rabbits and cats. Exp Eye Res 1973 0.75
162 T-cell reactivity to polymorphic MHC determinants. I. MHC-guided T-cell reactivity. Curr Top Microbiol Immunol 1986 0.75
163 In vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations. Cell Immunol 1993 0.75
164 Targeting of exogenous protein antigens to a novel endosomal processing pathway for class I-restricted presentation. Behring Inst Mitt 1994 0.75
165 Clonal specificity analysis of mitogen-activated murine T lymphoblasts. Immunobiology 1987 0.75
166 "Self-reactive" T cells. II. Transferred syngeneic lymphoblasts induce T "stimulator" cells in vivo, to which syngeneic T cells "respond" in a syngeneic MLC in vitro. Immunobiology 1980 0.75
167 DNA-Based Vaccination Primes Tumor-Rejecting T-Cell Responses. Methods Mol Med 2000 0.75